Abstract
The diverse clinical symptoms associated with systemic lupus erythematosus (SLE) probably reflect its complex genetic underpinnings. Evidence from a new study indicates that analysis of common risk alleles can predict susceptibility to several end-organ manifestations of SLE, which could influence patient screening and support personalized approaches to treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 623-624 |
Number of pages | 2 |
Journal | Nature Reviews Rheumatology |
Volume | 7 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2011 |
ASJC Scopus subject areas
- Rheumatology